Search

Home > New FDA Approvals > 138 - Kymriah for large B-cell lymphoma; women underrepresented in some clinical trials; FDA takes action against kid friendly e-cigarette products.
Podcast: New FDA Approvals
Episode:

138 - Kymriah for large B-cell lymphoma; women underrepresented in some clinical trials; FDA takes action against kid friendly e-cigarette products.
Category: Science & Medicine
Duration: 00:11:23
Publish Date: 2018-05-02 06:00:00
Description:

May 2, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:47 Kymriah® (tisagenlecleucel), first-in-class CAR-T therapy from Novartis, receives second FDA approval to treat appropriate r/r patients with large B-cell lymphoma https://www.prnewswire.com/news-releases/kymriah-tisagenlecleucel-first-in-class-car-t-therapy-from-novartis-receives-second-fda-approval-to-treat-appropriate-rr-patients-with-large-b-cell-lymphoma-300640525.html 

3:56 FDA analysis: Women underrepresented in HF, CAD, ACS trials https://www.healio.com/cardiology/practice-management/news/online/%7B45e37674-7615-46d9-b76f-746e5747e9e9%7D/fda-analysis-women-underrepresented-in-hf-cad-acs-trials 

5:56 FDA, FTC take action against companies misleading kids with e-liquids that resemble children’s juice boxes, candies and cookies https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm605507.htm 

AI in Medicine is a weekly podcast that covers the latest medically related developments in AI and is directed towards a clinician audience.  For more information, please go to aimedicinenews.com

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0